Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: implications of insulin treatment: a report from the GLORIA-AF Registry Phase III

31 August 2024 (11:25 - 11:35)
Organised by: Logo
Congress Presentation Part of: Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by